All posts by medical

Grey’s Anatomy Finds A Rainbow Connection – Long Island Weekly News

Jake Borelli as Dr. Levi Schmitt on Greys Anatomy. (Photo by ABC/Mike Rosenthal)By Louis Ghiraldi

If you have ever spent any time in a hospital, you are probably familiar with the term STAT, a fast-moving response to an urgent situation. In a lot of ways, STAT can also apply to the career of Jake Borelli who currently plays Dr. Levi Schmitt in the long-running ABC medical drama Greys Anatomy.

Although Borelli has been a veteran actor from an early age, his current meteoric success is finding the Ohio natives career gaining considerable momentum.

Unlike some of todays actors, Borelli succeeds because of substance rather than style and looks alone. He carries himself in a genuine natural way that resonates with the public and personifies authenticity. Borelli is a social media star with almost 400,000 followers on Instagram and an ever-expanding Twitter presence as well. His fans remain extremely loyal and wont be forgetting about him anytime soon. Borelli interacts with members of his fan base on a regular basis in a sincere and appreciative manner.

The kid from Columbus has come full circle this year, returning to his hometown to be King of the Pride parade, out and successful.

Borelli without hesitation points out, It was special to return home fully out of the closet with my whole family there. That special moment has been repeated on numerous occasions since he came out publicly 12 months ago.

Ive had the chance to meet so many wonderful people who have accepted me and offered kindness, is how he reflects on this whirlwind period. In his down-to-earth manner, Borelli adds that its about being himself and never changing his kind approach to interacting with people.

Those early days after he came out of the closet were complicated and found him personally going into uncharted waters.

I was terrified, and had no idea of what to expect, he said. There was pressure to be open and hope people would respect my decision.

In a case of art imitating life, Greys recently introduced its first gay male storyline that revolved around Borellis character, Levi Schmitt. It was an opportunity that Borelli felt made it the right time to come out in his personal life. Even casual viewers of the show can see how the series stories intersect with each other and how the characters grow, flaws and all.

Borelli points out We tell human stories, that everyone can relate to.

His fans have certainly related to him. Given how hes risen to become one of the more popular young actors on television, it wouldnt be surprising to see ABC lock him up with a long-term development deal for Greys Anatomy and beyond. Borelli remains an integral part of the show. The growth of his character and in his personal life have transcended the television screen and hit home with viewers. Chalk it up to the genuineness Borelli brings to this role that has earned him such broad appeal with viewers.

I try to bring vulnerability to every role that I play is how he describes it.

As a 10-year veteran plying his trade in Los Angeles, Borelli found early success playing Wolfgang in the Nickelodeon comedy series The Thundermans and the Netflix dramatic film Reality High. He also scored guest shots on NCIS: Los Angeles, Parenthood and True Jackson, VP before landing his current role on Greys Anatomy.

While maintaining a busy production schedule, Borelli remains very active in his charity work, working with AIDS Walk LA, the LGBTQ Center and the GLAAD Awards. His interests in these events is heartfelt and his commitment is never-ending. It was through these charitable causes that Borelli found his new creative passiondoing stand-up comedy in Los Angeles. Early reviews have been good and given how much Borelli enjoyed it, this might not be the last time you see him cracking jokes on stage.

Borelli has diverse interests, ranging from needlepoint to traveling and his love of actress Catherine OHara. Even if he had stayed in Columbus, Borelli says I would have been a painter and still pursued acting.

Currently taking singing lessons, Borelli enjoys coming to New York multiple times a year to binge Broadway shows over a few days. The 28-year-old thespian is always on the go, suitcase packed and ready to travel at a moments notice. Japan has been his favorite country to visit so far and Brazil is on his bucket list.

We have such a huge [South American] fan base, I would love to go visit.

As for his current gig, Borelli is thrilled to see that Greys Anatomy is showing no signs of slowing downhitting the 20-year mark seems like a given at this point.

I love it here. I want to stay as long as they will have me, he said of the show and his cast mates.

The network clearly has faith in its young phenom as Borelli has been cast to star in The Thing About Harry, which premieres in February on Freeform (formerly ABC Family).Greys Anatomy returns to ABC on Jan. 23.

Read this article:
Grey's Anatomy Finds A Rainbow Connection - Long Island Weekly News

Greys Anatomy Recap: The Pen Is Mightier Than the Scalpel Plus, [Spoiler] Is Moving to Pac-North! – Sunriseread

We knew from final weeks Grays Anatomy that the article that Meredith was writing wasnt going to win her any buddies on the medical board not with doable titles like If You Die On Our Watch, Well Nonetheless Bankrupt Your Household. However neither we nor she may have guessed at the method her story concepts could be twisted into Hospital Hell at Gray Sloan Memorial. Learn on, and well not solely talk about simply how exhausting Bailey hit the roof when she learn the pieced-together piece, well reveal who dared to problem chief of chiefs Tom, and who was courted to leap ship from Gray Sloan to Pac-North.

BAILEYS GOING TO KILL ME! | As Its Raining Males started (and with out even a riff of the Climate Ladies basic to start out us off), Mers attractive morning bedtime with DeLuca was interrupted by Amelia and Maggie, who revealed what the web site to which shed submitted her story concepts had carried out with them. To place it mildly, it wasnt fairly. At Gray Sloan, Jackson knowledgeable Vic that the article included an inventory, which appeared to, as Helm put it, torch the hospital, and Owen knowledgeable Bailey that he was out till Toms restraining order was lifted. The first that the chief heard about Grays story was when a affected person panicked and refused to be admitted. In the locker room, we discovered that Dahlia had gotten a job in Michigan. So no switch to Pac-North for her, I suppose. Talking of Pac-North, Alex discovered {that a} psych affected person had been discovered earlier than he had wound up passing himself off as a physician. Soyay? Again at Gray Sloan, Bailey didnt need to hear from DeLuca that Mer had been as stunned as she was by what had been carried out with the data she supplied the web site. As an alternative, since a Dr. Kang had give up over the listing, Bailey made Mers boyfriend chief resident. You possibly can repair what your girlfriend broke, she hollered at him.

In the meantime, Jackson balked at Toms concept to videotape his surgical procedure on a baby as a method of controlling the harm from Mers article, and Teddy handled a girl named Alicia who had a man fall from a aircraft on high of her. As will occur? (Oh, thats why it was raining males. Hallelujah!) As for Jacksons case, it was going to contain fixing the little ladys cranium at no cost which was information to him. Simply after I thought I couldnt probably such as you much less, Jackson huffed to Koracick, who had mainly bribed the dad and mom into letting the surgical procedure be used as a promotional software. As the episode went on, Tom solely disgusted Jackson increasingly more. And actually, he was tremendous creepy, making an attempt to get the ladys dad to redo an interview simply because the lighting had been dangerous. The places the Koracick wed come to know and love? When Jackson stood as much as Tom, Koracick reminded Catherines son that Mother had made him the boss. Off a chat with Jo, during which she identified that Mer, having been canned, may simply do the proper factor, Jackson went to his younger affected persons dad and mom and requested that they bump Tom from the surgical procedure and substitute him with Amelia. Your little lady means extra to me than some good press, he defined. And instantly, they agreed to have Amelia scrub in rather than Koracick. That Tom was gonna blow a gasket was, in Jacksons estimation, an added bonus. When Koracick interrupted the surgical procedure, Jackson reminded him that he was actually his boss, not the different method round. In response, Tom marveled that Jackson had blown a ton of nice press that mightve helped put out the fireplace Mer had began, and had taken conceitedness to a stage that even he had by no means achieved. After the miraculous operation was accomplished, Schmitt instructed that Jackson had made a mistake by not letting its filmed certain, Jacksons profession was safe, however not everybody was that fortunate.

THIS PLACE IS REALLY SHAPING UP | At Pac-North, Owen arrived with the affected person who had refused therapy at Gray Sloan. When Alex heard that Hunt was taking a while off to remain at dwelling with Leo and Allison, he leapt into motion, providing to take his former colleague on a tour. Clearly, he noticed a possible recruit. And it appeared that he is perhaps making headway with Owen, too, once they have been distracted by a scream. A affected person was bleeding throughout the place as a result of no check had been carried out to see if the blood he was given would coagulate. A lot for Pac-North shaping up. Whereas treating the bloody affected person, Alex flat out requested Owen to come back pitch in with him and Richard at Pac-North. Hunt didnt must put up with Koracick and his BS.

MEREDITH CALLS BOWEL RESECTIONS HER ME TIME | Becoming a member of Teddy, Hyperlink and Taryn in treating Alicia, Maggie impressed Vic. Shes form of a genius, isnt she? the firefighter requested Ben, just about rhetorically. Close by, Hyperlink tended to Alicias boyfriend Josh, who gave the impression to be going into shock he discovered himself holding the severed thumb of the man whod fallen from the sky. After Alicia died throughout surgical procedure, Teddy wept that the complete world was damaged, a truth made even worse by the proven fact that she now had a daughter. In different developments, whenthe medical web site dragged its toes altering the headline on Mers article, she ticked off her litter-pickup supervisor Lisa by strolling off the job to attempt to do her personal harm management with Bailey. (Transfer to Switzerland was the recommendation that Cristina texted her pal.) When Mer arrived at Gray Sloan, Jo warned her that Bailey may ask her to take again her title from little Bailey it was that dangerous. And the listing wasnt Mirandas solely concern. Although her stress stage all through the episode was via the roof, Maggie suspected that that wasnt the motive Bailey was so heat it is perhaps, er, hormonal, Pierce instructed. Later, Bailey wept to Ben that she knew it was coming sometime. However now that it was right here, it was exhausting. Nobody warns you about all the emotions, she cried. Might he assist? Simply sit along with her, she pleaded.

When Mer got here head to head with Bailey, she defined that the majority of what was in the article wasnt even directed at Gray Sloan. Miranda understood on one hand, however on the different, the harm has been carried out. As the hour drew to a detailed, Tom bumped into Owen with Teddy at Gray Sloan, and knowledgeable Hunt that he was lifting the restraining order. It didnt matter, although Owen was going to work at Pac-North. After Josh broke down in entrance of Hyperlink over Alicias demise, he let Amelia act as his weighted blanket and confessed that he thought he was in love along with her. Love results in divorce, to ache, he mentioned. However Im feeling it, Im fairly certain, and its a sense I like and I wanna title, as a result of typically individuals fall out of the sky. Her response: OK. Oh, Limelia, you two are the finest. Lastly, Mer stuffed in DeLuca on her speak with Bailey and the proven fact that she now needed to seem in courtroom for strolling off work crew. He argued that she ought tove labored inside the system fairly than do what she had she didnt want any extra enemies at the second. Yeah? Effectively, she didnt want his lecturing, both, she huffed. And Maggie reported to Bailey that she was each perimenopausaland pregnant! Please inform me youre not going to maintain it a secret, Pierce pleaded.

So, what did you consider Its Raining Males? Hyperlinks confession? Owens determination? Baileys being pregnant? Remark away.

Go here to read the rest:
Greys Anatomy Recap: The Pen Is Mightier Than the Scalpel Plus, [Spoiler] Is Moving to Pac-North! - Sunriseread

Immunology Market Share, Revenue, And Average Worth By Makers Shared In An Exceedingly Latest Analysis Report – Expert Recorder

The Immunology market report [5 Years Forecast 2020-2025] focuses on Major Leading Industry Players, providing info like Immunology market competitive situation, product scope, market overview, opportunities, driving force and market risks. Profile the top manufacturers of Immunology, with sales, revenue and global market share of Immunology are analyzed emphatically by landscape contrast and speak to info. Upstream raw materials and instrumentation and downstream demand analysis is additionally administrated. The Immunology market business development trends and selling channels square measure analyzed. From a global perspective, It also represents overall industry size by analyzing qualitative insights and historical data.

The study encompasses profiles of major companies operating in the global Immunology market. Key players profiled in the report includes : AbbVie, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Bionor Pharma, Celgene, Cellectar Biosciences, eFFECTOR Therapeutics and among others.

Get Free Sample PDF (including full TOC, Tables and Figures) for more Professional and Technical insights @https://www.researchmoz.us/enquiry.php?type=S&repid2040006

This Immunology market report provides a comprehensive analysis of:Industry overview, cost structure analysis, technical data and competitive analysis, topmost players analysis, development trend analysis, overall market overview, regional market analysis, consumers analysis and marketing type analysis.

Scope of Immunology Market:

The global Immunology market is valued at million US$ in 2019 and will reach million US$ by the end of 2025, growing at a CAGR of during 2020-2025. The objectives of this study are to define, segment, and project the size of the Immunology market based on company, product type, application and key regions.

This report studies the global market size of Immunology in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Immunology in these regions.

This research report categorizes the global Immunology market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors, customers, research findings & conclusion, appendix & data source and Porters Five Forces Analysis.

The end users/applications and product categories analysis:

On the basis on the end users/applications,this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Immunology foreach application, including-

On the basis of product,this report displays the sales volume, revenue (Million USD), product price, Immunology market share and growth rate ofeach type, primarily split into-

Do You Have Any Query Or Specific Requirement? Ask to Our Industry [emailprotected]https://www.researchmoz.us/enquiry.php?type=E&repid2040006

(*Fill the form and our sales representative will get back to you for assistance)

Immunology Market : The Regional analysis covers:

The Crucial Questions Answered by Immunology Market Report:

The report offers exclusive information about the Immunology market, based on thorough research about the macro and microeconomic factors that are instrumental in the development of the market. The information featured in this report can answer salient questions for companies in the Immunology market, in order to make important business-related decisions. Some of these questions include:

And Many More.Contact Us:

ResearchMozMr. Nachiket Ghumare,Tel: +1-518-621-2074USA-Canada Toll Free: 866-997-4948Email: [emailprotected]Follow us on LinkedIn @ http://bit.ly/2RtaFUo

Follow me on : https://marketnews-24.blogspot.com/

Read more:
Immunology Market Share, Revenue, And Average Worth By Makers Shared In An Exceedingly Latest Analysis Report - Expert Recorder

Cytovia Therapeutics and the University of California, San Francisco enter into a partnership to develop precision gene-edited CAR-NK cell therapy -…

SAN FRANCISCO and NEW YORK, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Cytovia Therapeutics, a biopharmaceutical company, and the University of California, San Francisco (UCSF) announced today that they have entered a 3-year research partnership to develop novel precision gene editing to improve the performance, safety and persistence of Natural Killer (NK) cells and Chimeric Antigen Receptor (CAR)-NK cells. The lead investigator is Justin Eyquem, PhD, a Principal Investigator in the Microbiology & Immunology Department at UCSF. Cytovia will have an exclusive option to license certain patentable inventions developed as part of the research program.

Dr Daniel Teper, CEO of Cytovia said: Cytovia is committed to advancing the development of NK biotherapeutics with a primary focus on off the shelf CAR NK cells and multispecific antibodies. The partnership with UCSF will utilize advanced gene editing technology to develop precision CAR NK cell therapeutics for both solid and hematological cancers.

Dr Justin Eyquem, of UCSF added: With their safer profile, their natural antitumor activity through a variety of receptors and their allogeneic potential, NK cells are a great addition to the adoptive therapy field. We strongly believe that precision gene editing and rational CAR design will not only make CAR NK cells stronger and safer, but also greatly standardize their manufacturing.

About Cytovia Therapeutics: Cytovia is dedicated to the development of transformational cancer immunotherapies, addressingseveral of the most challenging unmet medical needsincluding the prevention of cancer relapse and metastasis. Cytovia focuses on Natural Killer (NK) cell biology and applies precision medicine tools to develop the right therapy for the right patientat the right stage of the disease. Cytovia has secured access to multiple advanced technologies, including allogeneic cell therapy, multispecific antibodies, and cytokines.Cytovia establishes development partnerships to accelerate time-to-market and commercialization alliances in order to optimize rapid adoption of its novel immunotherapies.

About UCSF:The University of California, San Francisco (UCSF) is exclusively focused on the health sciences and is dedicated to promoting health worldwidethrough advanced biomedical research, graduate-level education in the life sciences and healthprofessions, and excellence in patient care. It includes UCSF Health, which comprises three top-ranked hospitals, as well as affiliations throughout the Bay Area. Learn more athttps://www.ucsf.edu,or see ourFact Sheet.

Contact information:

CYTOVIA Therapeutics:Anna Baran-DjokovicVP, Corporate Affairsanna@cytoviatx.com

Cytovia Media Contact:Charlotte Tomiccharlotte@tomiccommmunications.comCell 9178825243

UCSF Media:Laura KurtzmanSenior Public Information Officer1-415-476-3163laura.kurtzman@ucsf.edu

The rest is here:
Cytovia Therapeutics and the University of California, San Francisco enter into a partnership to develop precision gene-edited CAR-NK cell therapy -...

HIV-Associated Immune Amnesia Could Explain Why HIV-Positive People Have Shorter Lives – PrecisionVaccinations

A new study led by the Oregon Health & Science University School of Medicine and Oregon National Primate Research Center found Human Immunodeficiency (HIV) patients lose immunity to smallpox, even though they were vaccinated against the disease as children.

Called HIV-associated immune amnesia, this finding published on January 2, 2020, could explain why people living with HIV still tend to have shorter lives on average than their HIV-negative counterparts, despite being on antiretroviral therapy.

This new study was published in the Journal of Infectious Diseases and follows other research recently published in the journals Science and Science Immunology that found the immune systems of children who contracted measles similarly "forgot" their immunity against other illnesses, such as influenza.

The previous study was published on October 31, 2019, found measles infections in children can eliminate the immune systems memory to fight off other illnesses.

That was the first study to show definitive evidence that a measles virus infection can destroy important immune cells that remember previous encounters with specific bacteria.

Led by Mark K. Slifka, Ph.D., a professor of molecular microbiology and immunology at the Oregon Health & Science University School of Medicine and Oregon National Primate Research Center, this new study compared T-cell and antibody responses of a total of 100 HIV-positive and HIV-negative women who were vaccinated against smallpox in their youth.

The research team chose smallpox because its last known U.S. case was in 1949, meaning study subjects haven't recently been exposed to its virus, which would have triggered new T-cell and antibody responses.

They found the immune systems of HIV-positive women who were on antiretroviral therapy had a limited response when their blood was exposed to the vaccina virus, which is used in the smallpox vaccine.

Normally, those vaccinated against smallpox have CD4 T cells that remember the virus and respond in large numbers when they're exposed again. Previous research has shown smallpox virus-specific CD4 T cells are maintained for up to 75 years after vaccination.

This finding happened despite the fact that antiretroviral therapy works by boosting CD4 T cell counts in HIV-positive patients. This indicates that while antiretroviral therapy may boost total T cell counts overall, it can't recover virus-specific T cells generated from prior childhood vaccinations.

Dr. Slifka and his colleagues plan to evaluate whether the same phenomenon occurs in HIV-infected men and if people living with HIV also lose immune memory to other diseases.

Researchers who contributed to this study are affiliated with OHSU, SUNY Downstate, Georgetown University, Cornell University, University of Southern California and John Hopkins University.

This research was supported by the National Institutes of Health Public Health Service (grant U19 AI109948) and the Oregon National Primate Research Center (grant 8P51 OD011092).

HIV vaccine news published by Precision Vaccinations.

See more here:
HIV-Associated Immune Amnesia Could Explain Why HIV-Positive People Have Shorter Lives - PrecisionVaccinations

Common fruitfly at the centre of global meet in Pune in modern biology – Hindustan Times

PUNE National and international experts from various streams of biology, cancer and DNA damage, immunology and memory formation in the brain have gathered in Pune to discuss deep research into the common fruitfly at the 5th Asia Pacific Drosophila Research Conference (APDRC5) and Indian Drosophila Research Conference that began here today.

Two Nobel laureates, Eric Wieschaus and Michael Rosbash, renowned for their work in development biology and chronobiology respectively, are among the 100 international and 330 Indian participants in this five-day conference, being held in the country for the first time.

Organised by the Indian Institute of Science Education and Research (IISER), Pune, IISERs Professor (Biology) Sutirth Dey said, This meeting is special for us because the Indian scientific community is very strong in Drosophila. This is one of those meetings in which, absolutely, the whos who of drosophoila biology from all over the world are coming. They are not only going to meet other scientists but also the post-doctoral, PhD students and under-graduates, he said.

Dey, who is using Drosophila for research in Ecology and Evolution said this common fruitfly has a very different kind of immune system from humans and yet, some pathways are common.

It has been one of the most widely-used model organism in the world for research in life sciences over the last 100 years because its genome has been entirely sequenced and there is enormous information available about its biochemistry, physiology and behaviour, he said.

The entire process of development from a cell to a full-fledged organism has been studied in Drosophila. Scientists have found that many similarities exist between Drosophila and higher organisms and therefore this research is very useful, said Dey.

One of the highlights of the Pune conference is the participation of under-graduate, post-graduate and PhD students from top institutes across the country. Fifty six under-graduate students from nine institutes across India and 13 students from nine foreign institutes in the US, Japan, China and Taiwan are participating in this conference.

Drosophila brings together a range of experts such as developmental biologists, neurobiologists, evolutionary biologists, molecular biologists and others, all of who discuss their insights into the drosophila system.

Some of the top scientists participating are K Vijayaraghavan, developmental biologist and principal scientific advisor to Government of India, Developmental biologist LS Shashidhara; evolutionary biologist Amitabh Joshi; Subhash Lakhotia, a specialist in Chromosome Biology and Rakesh Mishra, an expert in Genomics and Epigenetics.

Trudi Schupbach, an expert on cancer and DNA damage from Princeton University; Gines Morata, an expert on formation of body patterns and gene functions from Spain; Kenji Matsuno, from Osaka University, and Ann Shyn Chiang, an expert on memory formation in brain from the National Tsing Hua University, Taiwan, are among those participating at the event.

See the rest here:
Common fruitfly at the centre of global meet in Pune in modern biology - Hindustan Times

These 6 Simple Exercises Can Cut Body Weight, Even if You’re Predisposed to Obesity – ScienceAlert

We know that a range of factors influence weight, including those related to lifestyle and genetics, but researchers have now identified six specific exercises that seem to offer the best chance of keeping your weight down even if your genes don't want you to.

Based on an analysis of 18,424 Han Chinese adults in Taiwan, aged between 30 and 70 years old, the best ways of reducing body mass index (BMI) in individuals predisposed to obesity are: regular jogging, mountain climbing, walking, power walking, dancing (to an "international standard"), and lengthy yoga practices.

But interestingly, many popular exercise types weren't shown to do much good for those who's genetic risk score makes them more likely to be obese.

Specifically, exercises including cycling, stretching, swimming and legendary console game Dance Dance Revolution don't appear to be able to counteract genetic bias (though are beneficial in many other ways).

"Our findings show that the genetic effects on obesity measures can be decreased to various extents by performing different kinds of exercise," write the researchers in their paper published in PLOS Geneticsin August 2019.

"The benefits of regular physical exercise are more impactful in subjects who are more predisposed to obesity."

Besides BMI, the team also looked at four other obesity measures for a more complete picture: body fat percentage (BFP), waist circumference (WC), hip circumference (HC), and waist-to-hip ratio (WHR).

Regular jogging 30 minutes, three times a week turned out to be the most effective way of counteracting obesity genes across all of them.

The researchers also suggest, based on the information dug up in the Taiwan BioBank database, that the less effective forms of exercise typically don't use up as much energy, which is why they don't work quite so well.

The researchers specifically noted that activities in cold water, such as swimming, could make people hungrier and cause them to eat more.

The study was able to succeed in one of its main aims, which was to show that having a genetic disposition towards obesity doesn't mean that obesity is inevitable the right type of exercise, carried out regularly, can fight back against that built-in genetic coding.

"Obesity is caused by genetics, lifestyle factors, and the interplay between them," epidemiologist Wan-Yu Lin, from the National Taiwan University, told Newsweek. "While hereditary materials are inborn, lifestyle factors can be determined by oneself."

It's worth noting that not every type of exercise was popular enough within the sample population to be included: activities like weight training, table tennis, badminton or basketball may or may not be helpful, too. There wasn't enough data to assess.

But with obesity numbers rising sharply across the world and 13 percent of the global population now thought to quality as being obese it's clear that measures need to be taken to reverse the trend.

Being obese affects our physiological health in the way it increases the risk of cardiovascular disease, some cancers, and other issues; and there's evidencethat being seriously overweight can have a negative effect on our brains too.

Studies like this latest one can point towards ways of sticking at a healthy weight, even when the genetic cards are stacked against it. In some cases all it takes is a few minutes of exertion per day.

"Previous studies have found that performing regular physical exercise could blunt the genetic effects on BMI," conclude the researchers.

"However, few studies have investigated BFP or measures of central obesity. These obesity measures are even more relevant to health than BMI."

The research has been published in PLOS Genetics.

A version of this article was first published in August 2019.

Originally posted here:
These 6 Simple Exercises Can Cut Body Weight, Even if You're Predisposed to Obesity - ScienceAlert

How genetics and social games drive evolution of mating systems in mammals – Jill Lopez

Traditional explanations for why some animals are monogamous and others are promiscuous or polygamous have focused on how the distribution and defensibility of resources (such as food, nest sites, or mates) determine whether, for example, one male can attract and defend multiple females.

A new model for the evolution of mating systems focuses instead on social interactions driven by genetically determined behaviors, and how competition among different behavioral strategies plays out, regardless of external factors such as defensible resources. In this model, social interactions can drive evolutionary transitions from one mating system to another, and can even drive a population to split into two separate species with different mating systems.

The model is based on three fundamental behavioral strategies: aggression, cooperation, and deception. The conflict between competitive and cooperative social behaviors drives the evolution of the mating systems. In a paper published December 18 inAmerican Naturalist(online ahead of print publication in the February issue), researchers compared the predictions generated by this model with published data on the mating behavior of 288 species of rodents.

"By and large, everything in our predictions seems to be borne out in rodents," said first author Barry Sinervo, professor of ecology and evolutionary biology at the University of California, Santa Cruz. "Our model is a universal equation of sorts for mating systems."

The evolutionary story that emerges from the study goes something like this: An ancestral population of rodents is promiscuous in its mating behavior. Genetic variation within the population results in individuals with distinctive behaviors. Some males are highly aggressive, defend large territories, and mate with as many females as they can. Others are not territorial, but sneak onto the territories of other males for surreptitious mating opportunities. And some are monogamous and defend small territories, cooperating with neighboring males at territorial boundaries.

These three types can coexist, but any imbalance in the relative advantages of different strategies can lead to the elimination of some behaviors and an evolutionary transition to a species that is, for example, entirely monogamous or entirely polygamous. The cooperative behavior of monogamous males, for example, can include paternal care for the young and the ability recognize and affiliate with other cooperative males, making them stronger in the competition with other strategies.

"They are able to find each other and form colonies, and the bigger the colonies get the stronger they are against the barbarians at the gate. Then they split off from the rest of the population as a separate monogamous species," Sinervo said.

This may sound like little more than storytelling, but in fact it emerges from a set of mathematical equations based on game theory and population genetics, and it is supported by extensive research in animal behavior and genetics.

The new paper builds on Sinervo's decades-long research on mating behaviors in California's side-blotched lizards. He showed that three throat colors correspond with different behaviors in the male lizards: blue-throated monogamous males form partnerships and cooperate to protect their territories and their mates; orange-throated males are highly aggressive and usurp territories and mates from other lizards; and yellow-throated males sneak into the territories of other males to mate.

The competition between these strategies takes the form of a rock-paper-scissors game in which orange aggressors defeat blue cooperators, which defeat yellow sneakers, which defeat orange aggressors. Thus, no single type can dominate the population, and the abundance of each rises and falls in cycles. In 2007, Sinervo and his collaborators discovered the same dynamic in the distantly related European common lizard.

"That was when I started thinking that the same thing could be happening in mammals," Sinervo said.

In the new paper, Sinervo and two of his longtime collaborators--Alexis Chaine at the National Center for Scientific Research (CNRS) in Moulis, France, and Donald Miles at CNRS and Ohio University--generalized the rock-paper-scissors system and extended it to include additional behaviors such as paternal care for offspring (linked to monogamy). They focused on male strategies to simplify the analysis. Sinervo has documented corresponding female strategies in side-blotched lizards and is currently working to incorporate female strategies into the general model.

The three male behavioral strategies represented in the model are: - Polygyny, characterized by aggression to maintain large territories overlapping with several females, but without paternal care for the offspring, as seen in polygamous mating systems where one male mates with multiple females; - Monogamy, involving lower aggression and smaller territories, with cooperation at territorial boundaries and investment in paternal care; and - Sneak, a non-territorial strategy with no paternal care, resulting in sneaking behavior in otherwise territorial systems.

Using a computer to run a mathematical model of these strategies, the researchers simulated the evolution of mating systems over 1,000 generations, varying the strength of different parameters in each simulation. At the start of the simulations, the genes that determine the different strategies were assumed to be equally abundant in the population.

The results of the simulations revealed four evolutionarily stable outcomes determined by the interactions and payoffs (in terms of reproductive success) of the different behavioral strategies. Which stable outcome emerges depends on how much of an advantage each behavior provides.

One of the key factors influencing the effectiveness of a given strategy is a male's ability to recognize which behavioral group other males belong to and choose a neighborhood to settle in where his own strategy will have a competitive advantage. Cooperative, monogamous males need to recognize and affiliate with other cooperative males, whereas aggressive, polygynous males want to avoid other aggressive males and find cooperative males whose territories they can take over.

"It all depends on how good you are at finding the right neighborhood, or how good you are at cooperation and paternal care. By varying these parameters in the model, we were able to find the four different evolutionarily stable states," Sinervo said.

One stable outcome is the rock-paper-scissors dynamic documented in lizards, with the coexistence of all three male strategies. Another stable outcome is the coexistence of polygyny and sneak.

There are two stable outcomes in which only one strategy survives, either polygyny or monogamy. A mix of polygyny and monogamy is rare and unstable, eventually leading to a pure system of one or the other.

Turning to the empirical data, the researchers found evidence in studies of rodent behavior and territoriality of the mating systems and behavioral strategies described in the model. There is even a type of mole rat found in southern Africa that exhibits the rock-paper-scissors combo of all three male strategies that Sinervo discovered in lizards. He noted that, whereas mutual recognition of male strategies is based on throat colors in the lizards, in mammals it is more likely to be mediated by smells. "It's there, but we don't see it. We only saw it in lizards because of their bright colors," he said.

The researchers analyzed the phylogenetic tree of rodents (representing the evolutionary relationships among rodent species) and found the same patterns they had seen in the simulations. Species at the base of the phylogenetic tree, closer to the common ancestor of all rodents, tend to be promiscuous, with multiple mating strategies. Polygyny and monogamy very rarely occur together, but they frequently appear in sister species, suggesting they diverged from an ancestral population of mixed strategies.

The model showed that evolutionary transitions in mating systems are largely driven by increases in the benefits of monogamous behaviors. In rodents, monogamy is the most common evolutionary transition from a promiscuous ancestor, and more rodents are monogamous than polygynous. In the simulations, pure polygyny is a relatively uncommon outcome. "Polygyny is readily invaded by the sneak strategy," Sinervo explained.

Paternal care for the offspring is found in all monogamous species, supporting a key assumption linking paternal care to the evolution of monogamy.

"Promiscuity is very common, and can involve two or three different strategies. But the neat thing is that cooperation and monogamy are far more common than anyone realized," Sinervo said. "The frequency of monogamy in rodents is about 26 percent, much higher than for mammals in general and similar to primates."

The model assumes that these behavioral strategies are genetically based. Evidence in support of this includes research on the role of the hormone vasopressin (and the related hormone oxytocin) in complex social behaviors in numerous species, including rodents and humans. In the monogamous prairie voles, for example, vasopressin has been linked to pair bonding, mate guarding, and paternal care. In some rodent lineages, evolutionary transitions between monogamy and polygyny have been linked to a mutation in a vasopressin receptor gene.

The effects of the genes underlying monogamous behaviors may even drive the evolution of more advanced forms of sociality. Highly social species of rodents--such as mole rats, some of which live in colonies in which only one pair reproduces--originate from monogamous lineages.

Sinervo and his coauthors are not claiming that resources and other external ecological factors have no role in the evolution of mating systems. But the genetic model gives predictions that are consistent with the rodent data and can explain cases where a species' mating system does not match its resource ecology.

The authors also acknowledged that animal behavior can be very flexible and is not entirely determined by genetics. This is especially true in humans, whose behavior is so strongly influenced by cultural and environmental factors. In terms of mating systems, our species can be described as promiscuous, but with very high rates of monogamy. Sinervo said he sees a connection between monogamy and the deeply cooperative social behaviors that are at the core of the human condition.

"We can see analogues for human behavior in other animals, but there's really nothing else like humans," Sinervo said. "There are 'kneejerk' behavioral impulses in us that are not far from rodents, but our cultural and social complexity makes us very different from most mammals."

See the article here:
How genetics and social games drive evolution of mating systems in mammals - Jill Lopez

New Publication Demonstrates GeneSight Improved All Clinical Outcomes Using HAM-D6 Analysis in Large Prospective GUIDED Study – Associated Press

SALT LAKE CITY, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, Myriad or the Company), a global leader in molecular diagnostics and precision medicine, announced that a new analysis of the GUIDED1 clinical trial using the 6-item Hamilton Depression Rating Scale (HAM-D6) was published online in BMC Psychiatry. The key finding is the HAM-D6 scale identified statistically significant improvements in all three clinical endpoints remission, response and symptoms between GeneSight-guided care and treatment-as-usual at Week 8 (Figure 1).

The HAM-D6 scale has been shown to be a better measure of core depressive symptoms than the HAM-D17 scale, said Boadie W. Dunlop, M.D., one of the study investigators and associate professor of Psychiatry and Behavioral Sciences at Emory University School of Medicine. This post hoc analysis provides further evidence that the GeneSight test led to significant and clinically meaningful improvements in clinical outcomes for patients with major depressive disorder relative to treatment-as-usual care.

To view Figure 1: GeneSight Test Significantly Improved Clinical Outcomes by Week 8 (HAM-D6), please visit the following link: https://www.globenewswire.com/NewsRoom/AttachmentNg/980daabb-fd8c-4bbb-b56e-48795fa16bdb

The GUIDED study was the largest prospective study to assess the benefit of pharmacogenomics-guided treatment for depression using the GeneSight Psychotropic test versus an active therapy control arm. All patients in the GUIDED study had the 17-item HAM-D17 questionnaire administered by blinded off-site raters as part of the study protocol. The 6-item HAM-D6 score represents a subset of HAM-D17 questions that have been shown to be more directly linked to depression. For example, questions such as have you had trouble sleeping which could be associated with conditions other than depression are excluded from the HAM-D6 score. Clinical studies have shown that the HAM-D6 score is superior to HAM-D17 at discriminating antidepressants from placebo.

About GeneSight PsychotropicGeneSight Psychotropic is a pharmacogenomic test that analyzes clinically important variations in DNA. The results of the test can inform doctors about genes that may impact how their patients metabolize or respond to depression medications.

About Myriad GeneticsMyriad Genetics Inc., is a leading precision medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on five critical success factors: building upon a solid hereditary cancer foundation, growing new product volume, expanding reimbursement coverage for new products, increasing RNA kit revenue internationally and improving profitability with Elevate 2020. For more information on how Myriad is making a difference, please visit the Companys website: http://www.myriad.com.

Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, EndoPredict, Vectra, GeneSight, riskScore, Prolaris, ForeSight and Prequel are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.

Safe Harbor StatementThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to a new analysis of the GUIDED clinical trial published online in BMC Psychiatry; and the Companys strategic directives under the caption About Myriad Genetics. These forward-looking statements are based on managements current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: the risk that sales and profit margins of our molecular diagnostic tests and pharmaceutical and clinical services may decline; risks related to our ability to transition from our existing product portfolio to our new tests, including unexpected costs and delays; risks related to decisions or changes in governmental or private insurers reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services and any future tests and services are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities and our healthcare clinic; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; risks related to our projections about our business, results of operations and financial condition; risks related to the potential market opportunity for our products and services; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents or other intellectual property; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and patents or enforcement in the United States and foreign countries; risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading Risk Factors contained in Item 1A of our most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2019, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. All information in this press release is as of the date of the release, and Myriad undertakes no duty to update this information unless required by law.

Media Contact: Ron Rogers Investor Contact: Scott Gleason (801) 584-3065 (801) 584-1143 rrogers@myriad.com sgleason@myriad.com

1 Greden JF, Parikh SV, Rothschild AJ, et al. Impact of pharmacogenomics on clinical outcomes in major depressive disorder in the GUIDED trial: A large, patient- and rater-blinded, randomized, controlled study. J Psychiatr Res. 2019; 111:59-67.

Link:
New Publication Demonstrates GeneSight Improved All Clinical Outcomes Using HAM-D6 Analysis in Large Prospective GUIDED Study - Associated Press

Global Chitin and Chitin Derivatives Market Industry Trends and Forecast to 2025 | Yunzhou Biochemistry Co., Advanced Biopolymers AS, Biophrame…

The global chitin and chitin derivatives market report provides with CAGR value fluctuation during the forecast period of 2018-2025 for the market. The numerical data is backed up by statistical tools such as SWOT analysis, porters five forces analysis and else. The readers will find this report very helpful in understanding the chitin and chitin derivatives market in depth. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and porters five forces analysis.

Get Sample Analysis of This Market Information:https://databridgemarketresearch.com/request-a-sample/?dbmr=global-chitin-chitin-derivatives-market

Global Chitin and Chitin Derivatives Market accounted for USD 2.3 billion in 2017 and is projected to grow at a CAGR of 15.8% during the forecast period of 2018 to 2025. The upcoming market report contains data for historic years 2015, 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Chitin is obtained from shrimp, crab and lobster waste. Chitin has wide range of application in food and beverages, agrochemical industry, healthcare industry among others. Some of the major players in Global Chitin and Chitin Derivatives Market include:-

Yunzhou Biochemistry Co.

Advanced Biopolymers AS

Biophrame Technologies

United Chitotechnologies Inc.

Koyo World (Hong Kong) Co. Ltd.

Dainichiseika Color & Chemicals Mfg. Co. Ltd.

Agratech LLC.

Kraeber & Co. GmbH

Foodchem International Corporation

FMC Corporation

GTC Bio Corporation

Panvo Organics Pvt., Ltd.

KitoZyme S.A.

Xianju Tengwang Chitosan Factory

Golden-Shell Pharmaceutical Co.

PT Biotech Surindo

TaizhouCandorly Sea Biochemical & Health Products Co. Lt

Heppe Medical Chitosan GmbH

Sonat Co

Kunpoong Bio Co. Ltd

The Global Chitin and Chitin Derivatives Market are fragmented with the presence of a large number of players across different regions. These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Get TOC For Full Analysis Of Report:https://databridgemarketresearch.com/toc/?dbmr=global-chitin-chitin-derivatives-market

Market Drivers:

Waste and water treatment to offer significant growth opportunities for chitin market in the coming years

Increasing need of chitin in biomedical and biopharmaceutical industry.

Easy raw material availability

Market Restraint:

As it is derived from natural resources such as crabs, extinction of the species may raise environmental concerns.

Synopsis of the report:

1. Major players and brands

2. Drivers and restrains of the market

3. Industry Chain Suppliers of Chitin and Chitin Derivatives Market with Contact Information

4. Historical, current and projected market size in terms of volume and value

5. In-depth market segmentation

6. Competitive landscape

Market Segmentation:

on the basis of Derivative Type

Glucosamine,

Chitosan,

Others

On the basis of end user:

Food and Beverages,

Agrochemical,

Healthcare,

Cosmetics and Toiletries,

Waste and Water Treatment,

Others

On the basis of geography:

North America,

South America,

Europe,

Asia-Pacific,

Middle East & Africa.

Note: If you have any special requirements, please let us know and we will offer you the report as you want.

Want Full Report? Enquire Here:https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-chitin-chitin-derivatives-market

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-281

Email: sopan.geda[emailprotected]

Go here to read the rest:
Global Chitin and Chitin Derivatives Market Industry Trends and Forecast to 2025 | Yunzhou Biochemistry Co., Advanced Biopolymers AS, Biophrame...